Sarepta Therapeutics, Inc. (SRPT) Social Stream



Sarepta Therapeutics, Inc. (SRPT): $146.38

2.60 (-1.75%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SRPT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#60 of 339

in industry

SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SAREPTA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 17 $160 $90 $127.25 $97.34 30.73%
2021-12-26 16 $160 $90 $127.076 $97.34 30.55%
2022-01-05 16 $160 $90 $126.538 $97.34 30%
2022-01-11 13 $160 $90 $128.083 $97.34 31.58%
2022-01-19 14 $160 $92 $128.25 $97.34 31.75%
2022-01-26 14 $160 $92 $126.833 $97.34 30.3%
2022-02-09 14 $160 $71 $125.083 $97.34 28.5%
2022-03-04 13 $150 $71 $121.909 $97.34 25.24%
2022-03-07 13 $150 $80 $122.727 $97.34 26.08%
2022-03-16 13 $150 $80 $123 $97.34 26.36%
2022-04-04 13 $150 $80 $124.3 $97.34 27.7%
2022-04-12 13 $150 $77 $124 $97.34 27.39%
2022-04-20 13 $150 $77 $124.2 $97.34 27.59%
2022-05-09 13 $150 $77 $124.1 $97.34 27.49%
2022-05-13 13 $150 $77 $124.6 $97.34 28%
2022-05-18 13 $150 $74 $124.3 $97.34 27.7%
2022-05-24 14 $155 $74 $127.09 $97.34 30.56%
2022-06-22 13 $155 $74 $127.09 $97.34 30.56%
2022-07-25 13 $155 $80 $126.272 $97.34 29.72%
2022-07-29 13 $162 $80 $127.363 $97.34 30.84%
2022-08-03 13 $162 $80 $127.583 $97.34 31.07%
2022-08-04 13 $162 $100 $132.076 $97.34 35.69%
2022-08-09 13 $182 $100 $133.769 $97.34 37.42%
2022-08-13 13 $182 $100 $134.923 $97.34 38.61%
2022-09-06 13 $182 $100 $136.461 $97.34 40.19%
2022-09-07 13 $182 $100 $137.461 $97.34 41.22%
2022-09-14 13 $182 $114 $140.153 $97.34 43.98%
2022-10-03 12 $182 $114 $140.153 $97.34 43.98%
2022-10-12 12 $182 $114 $141.916 $97.34 45.79%
2022-10-20 12 $182 $114 $143.5 $97.34 47.42%
2022-10-21 12 $182 $114 $144 $97.34 47.94%
2022-11-25 12 $190 $114 $146.153 $97.34 50.15%
2022-12-02 12 $190 $114 $146.846 $97.34 50.86%
2022-12-19 13 $190 $114 $147.642 $97.34 51.68%
2022-12-22 14 $190 $114 $148.466 $97.34 52.52%
2022-12-29 14 $190 $114 $150.066 $97.34 54.17%
2023-01-04 15 $190 $114 $151.533 $97.34 55.67%
2023-01-10 15 $190 $114 $151.666 $97.34 55.81%
2023-01-16 15 $190 $122 $152.4 $97.34 56.56%
2023-02-27 15 $190 $122 $153.4 $97.34 57.59%
2023-03-01 16 $190 $122 $154.933 $97.34 59.17%
2023-03-02 16 $226 $122 $169 $97.34 73.62%
2023-03-09 16 $226 $122 $172.533 $97.34 77.25%
2023-03-17 16 $226 $122 $171.666 $97.34 76.36%
2023-03-21 16 $226 $122 $171.333 $97.34 76.01%
2023-03-22 17 $226 $122 $174.666 $97.34 79.44%
2023-04-05 18 $226 $122 $174.058 $97.34 78.81%
2023-04-24 18 $226 $122 $173.823 $97.34 78.57%
2023-05-03 19 $226 $122 $174.444 $97.34 79.21%
2023-05-04 19 $206 $122 $170.222 $97.34 74.87%
2023-05-10 19 $206 $122 $171.5 $97.34 76.19%
2023-05-15 19 $206 $122 $173 $97.34 77.73%
2023-05-24 19 $218 $122 $177 $97.34 81.84%
2023-05-25 19 $218 $122 $176.722 $97.34 81.55%
2023-06-06 20 $218 $122 $175.368 $97.34 80.16%
2023-06-23 20 $218 $122 $175.421 $97.34 80.21%
2023-07-28 20 $218 $122 $181.263 $97.34 86.22%
2023-08-04 20 $218 $139 $184.555 $97.34 89.6%
2023-09-13 18 $223 $139 $186.647 $97.34 91.75%
2023-10-17 19 $223 $139 $186.647 $97.34 91.75%
2023-10-25 19 $223 $139 $186.176 $97.34 91.26%
2023-11-01 19 $223 $40 $167.875 $97.34 72.46%
2023-11-03 20 $215 $80 $146.5 $97.34 50.5%
2023-11-09 20 $215 $80 $146.312 $97.34 50.31%
2023-11-21 20 $224 $80 $150.882 $97.34 55.01%
2023-12-13 20 $224 $80 $145.294 $97.34 49.26%
2023-12-29 20 $224 $80 $141.058 $97.34 44.91%

The Trend in the Analyst Price Target


SRPT's average price target has moved down $29.16 over the prior 34 weeks.

Over the past 50 weeks, SRPT's average upside potential has been 48.89%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-16 14 190 122 153.400 126.70 21.07%
2023-02-27 15 190 122 153.400 118.13 29.86%
2023-04-24 18 226 122 173.823 126.68 37.21%
2023-08-04 20 218 139 185.000 105.31 75.67%
2023-12-13 20 224 80 145.294 92.11 57.74%

SRPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 14 2 4 0 0 20

The Trend in the Broker Recommendations


Over the past 17 months, SRPT's average broker recommendation rating worsened by 0.04.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SAREPTA THERAPEUTICS INC's average analyst price target is greater than 7088.94% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's number of analysts covering the stock is greater than 7511.93% of them.
  • SAREPTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 6786.14% of stocks in the large market cap category.
  • SAREPTA THERAPEUTICS INC's variance in analysts' estimates is lower than -5638.86% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SAREPTA THERAPEUTICS INC are MRVI, ABCL, and BLUE.

Is SRPT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!